Pittsburgh, Pennsylvania 15213


Purpose:

The goal of this study is to determine safety and tolerability of Losartan when used for treatment of an acute grade II or III hamstring strain and determining the effect of losartan on recovery of hamstring muscle function. Subjects will be adults age 18-35 with grade 2 or 3 hamstring injury who participate in Level 1 athletics or have a similar physical work load (e.g. military personnel). Military personnel will only be recruited at Brookings Medical Institute. Subjects will undergo examination, MRI, and functional assessment before, during, and after 4 weeks of losartan (50mg QD) or placebo.


Criteria:

Inclusion Criteria: 1. Between 18-35 years of age; 2. Have had grade II or III hamstring injury within the 7 days prior to enrollment; 3. Greater than 100 hours per year in Level I (football, basketball, or soccer) or Level II (racquet sports, skiing, manual labor occupations/heavy physical work) activities; 4. Agree to take study medications as prescribed Exclusion Criteria: 1. Have had previous hamstring injury on the same side or chronic symptoms; 2. Have an injury that requires surgical intervention (e.g. avulsion with associated bony involvement, grade III complete tears); 3. Have concurrent lower back symptoms; 4. Pregnant or breast feeding; 5. Is a smoker; 6. Has contraindications for Losartan therapy (hypersensitivity to Losartan, hepatic involvement); 7. Currently use angiotensin I converting enzyme inhibitor (ACEI)/ Angiotensin II receptor blocker (ARB); 8. Have hypertension (blood pressure greater than or equal to 140 mmHg systolic pressure or greater than or equal to 90 mmHg diastolic pressure); 9. Have hypotension (blood pressure less than or equal to 90 mmHg systolic pressure or less than or equal to 60 mmHg diastolic pressure); 10. Have orthostatic hypotension defined as a drop in systolic pressure greater than or equal to 2 0mmHg or a drop in diastolic blood pressure greater than or equal to 10 mmHg or reports of lightheadedness or dizziness upon standing; 11. Have diabetes mellitus, cardiovascular, renal or hepatic co-morbidities; 12. Have contraindications for MRI - including: - Prior surgery for an aneurysm; - Have cardiac pacemaker; - Have metal fragments in the eyes, brain, or spinal cord from shrapnel, metal work, or welding; - Have surgical implants, such as ear implant or neurostimulator; - Have a history of claustrophobia; - Have a history of not tolerating previous MRI scans without medication


NCT ID:

NCT02263729


Primary Contact:

James Irrgang, PT,PhD
Email: irrgangjj@upmc.edu


Backup Contact:

N/A


Location Contact:

Pittsburgh, Pennsylvania 15213
United States

James Irrgang, PT, PhD
Email: irrgangjj@upmc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: November 23, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.